Thursday, 5 November 2020

CBD (Cannabidiol) Market to Perceive Phenomenal Growth by 2026; Asserts MRFR Unleashing the forecast up to 2026

 CBD (Cannabidiol) Market Overview 

Cannabidiol (CBD) is a natural compound present in the cannabis resinous flower, a plant with a long history as a medicinal drug stretching back several decades. Today scientists and physicians around the world are researching and verifying the medicinal effects of CBD. CBD is one of over a hundred “phytocannabinoids,” a healthy, non-addictive drug that is specific to cannabis and that endows the plant including its robust medicinal profile. CBD is closely linked to another essential phytocannabinoid involved in the medicine: tetrahydrocannabinol (THC), the compound that induces the high medical marijuana is known for. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8090

CBD and THC both have great medicinal strengths. Unlike THC, however, CBD doesn’t really make someone feel intoxicated. This is because CBD and THC function on various brain receptors and bodies in differing ways. Indeed, CBD will mitigate or neutralize THC’s addictive properties, based on how much each compound is consumed. Most people like cannabis without the high-or with a little less a high-health benefit. The idea that CBD is both medicinally active and non-intoxic, and easier to take as a CBD oil, makes it an attractive treatment choice for those that try it for the first time. 

There’s plenty of hype about CBD’s healing abilities-for justifiable reason. But that wasn’t this until June 2018. Food and Drug Administration (FDA) has accepted cannabidiol as a true medication by recognizing Epidiolex, an almost pure form of prescription CBD, as a cure for two serious pediatric seizure disorders, Lennox-Gastaut syndrome and Dravet syndrome. It was the first time since the height of the reefer madness era 80 years ago – as “marihuana” was a felony rather than a treatment – that the administration gave an official thumbs-up for a drug extracted from cannabis. 

CBD Market Key Players

The prominent players in the global CBD market are Aphria Inc., Folium Biosciences, Freedom Leaf, Inc, Green Roads of Florida, LLC, CBD Health Solutions, LLC, ENDOCA, Isodiol International Inc, CV Sciences, Inc, Medical Marijuana, Inc., Canopy Growth Corporation, Elixinol Global Limited.

CBD (Cannabidiol) Market Segmentation 

CBD is not a wonder but a substance. Most people may greatly benefit from legal access to a wide variety of cannabis treatments, not just low-THC or no-THC products. CBD alone can not do the trick at all. There is ample evidence that CBD performs best when combined with THC and the wide range of other ingredients of cannabis. In order to understand the global CBD market in a better way, experts have segmented the market. 


Based on form, the market has been segmented into: 

  • Solid
  • Liquid 

By product: 

  • Food Grade
  • Therapeutic Grade 

By routes of administration: 

  • Tincture
  • Capsules
  • Inhalation (Smoke or Vapor)
  • Aerosol Spray 

By application: 

  • Fibromyalgia
  • Neurogenerative Disorder
  • Diabetes
  • Energy Drinks
  • Protein Bars

By end user: 

  • Food & Beverage
  • Healthcare 

By source: 

  • Organic
  • Inorganic 

CBD (Cannabidiol) Market Regional Overview 

These are of course exciting times for the CBD industry. Experts believe that CBD’s future looks bright, with big international retailers willing to store a wider variety of CBD items. That being said, sounding a cautionary note is essential. Big, scientific studies are still in dearth, and several questions need to be answered. To better understand the global market for CBD at regional levels, industry experts have segmented the market based on regions which include North America, Asia Pacific, Europe, and the rest of the world. The countries covered in the report are India, China, the United States, the United Kingdom, Australia, Japan, Germany, and others. 

CBD (Cannabidiol) Industry News 

Newly implemented government plans for tribal hemp development are giving a strategic advantage to US sovereign countries in cultivating the plant and selling CBD, the communities claim. Following 80 years of ban, when U.S. farmers race to grow hemp, tribal territorial authorities realize they have such an edge so they can avoid red tape to become the first merchants on state markets to sell very own CBD.

Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/cbd-market-8090

No comments:

Post a Comment